Evidence map›Paper›PMID 31796676›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.

Emilie T Reas, Donald J Hagler, Joshua M Kuperman, Christina E Wierenga, Douglas Galasko, Nathan S White, Anders M Dale, Sarah J Banks, Linda K McEvoy, James B Brewer

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Emilie T ReasDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Donald J HaglerDepartment of Radiology, University of California, San Diego, La Jolla, CA, USA.
Joshua M KupermanDepartment of Radiology, University of California, San Diego, La Jolla, CA, USA.
Christina E WierengaDepartment of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
Douglas GalaskoDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Nathan S WhiteDepartment of Radiology, University of California, San Diego, La Jolla, CA, USA.
Anders M DaleDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Sarah J BanksDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Linda K McEvoyDepartment of Radiology, University of California, San Diego, La Jolla, CA, USA.
James B BrewerDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
University of California, San Diego · USVA San Diego Healthcare System · US

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
Sex-specific cognitive expression and risk in preclinical Alzheimer's diseaseR01AG066088 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BANKS, SARAH · 2019 to 2023
$3.9M
Cognitive and Brain Changes in Preclinical Alzheimer's DiseaseI01CX000565 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI WIERENGA, CHRISTINA E · 2013 to 2022
–
CSRD VA I01 CX000565NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG066088
6 · The paper itself

Abstract

backgroundAlthough amyloid-β (Aβ) and microstructural brain changes are both effective biomarkers of Alzheimer's disease, their independent or synergistic effects on cognitive decline are unclear.

objectiveTo examine associations of Aβ and brain microstructure with cognitive decline in amnestic mild cognitive impairment and dementia.

methodsRestriction spectrum imaging, cerebrospinal fluid Aβ, and longitudinal cognitive data were collected on 23 healthy controls and 13 individuals with mild cognitive impairment or mild to moderate Alzheimer's disease. Neurite density (ND) and isotropic free water diffusion (IF) were computed in fiber tracts and cortical regions of interest. We examined associations of Aβ with regional and whole-brain microstructure, and assessed whether microstructure mediates effects of Aβ on cognitive decline.

resultsLower ND in limbic and association fibers and higher medial temporal lobe IF predicted baseline impairment and longitudinal decline across multiple cognitive domains. ND and IF predicted cognitive outcomes after adjustment for Aβ or whole-brain microstructure. Correlations between microstructure and cognition were present for both amyloid-positive and amyloid-negative individuals. Aβ correlated with whole-brain, rather than regional, ND and IF.

conclusionAβ correlates with widespread microstructural brain changes, whereas regional microstructure correlates with cognitive decline. Microstructural abnormalities predict cognitive decline regardless of amyloid, and may inform about neural injury leading to cognitive decline beyond that attributable to amyloid.

Indexed as

AgedAged, 80 and overAmyloid beta-PeptidesBrainCognitive DysfunctionDementiaDiffusion Tensor ImagingFemaleHumansLongitudinal StudiesMaleMiddle AgedNeural PathwaysNeuritesNeuropsychological TestsPlaque, AmyloidAmyloid beta-PeptidesAgingAlzheimer’s diseaseamyloidcognitive declinedementiadiffusion imagingmagnetic resonance imagingmemorymild cognitive impairment

Identifiers

PMID31796676
PMCPMC7266036
OpenAlexW2991117480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.